{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:00:24Z","timestamp":1793293224382,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010519","name":"Health Sciences Center New Orleans, Louisiana State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007015","name":"University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.virusres.2019.197829","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T11:17:17Z","timestamp":1575026237000},"page":"197829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Persistent HCMV infection of a glioblastoma cell line contributes to the development of resistance to temozolomide"],"prefix":"10.1016","volume":"276","author":[{"given":"Pankaj","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.virusres.2019.197829_bib0005","doi-asserted-by":"crossref","first-page":"11886","DOI":"10.1158\/0008-5472.CAN-07-2964","article-title":"Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks","volume":"67","author":"Batista","year":"2007","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.virusres.2019.197829_bib0010","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1128\/JVI.00015-12","article-title":"Genetic analysis of cytomegalovirus in malignant gliomas","volume":"86","author":"Bhattacharjee","year":"2012","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2019.197829_bib0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/(SICI)1097-0215(19960103)65:1<90::AID-IJC16>3.0.CO;2-M","article-title":"Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line","volume":"65","author":"Cinatl","year":"1996","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.virusres.2019.197829_bib0020","first-page":"3347","article-title":"Human cytomegalovirus infection and expression in human malignant glioma","volume":"62","author":"Cobbs","year":"2002","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.virusres.2019.197829_bib0025","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1099\/jgv.0.001118","article-title":"Impact of human cytomegalovirus on glioblastoma cell viability and chemotherapy treatment","volume":"99","author":"Dos Santos","year":"2018","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2019.197829_bib0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/rmv.1862","article-title":"Cytomegalovirus latency and reactivation: recent insights into an age old problem","volume":"26","author":"Dupont","year":"2016","journal-title":"Rev. Med. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2019.197829_bib0035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/neuonc\/nor227","article-title":"Consensus on the role of human cytomegalovirus in glioblastoma","volume":"14","author":"Dziurzynski","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.virusres.2019.197829_bib0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mrrev.2016.05.005","article-title":"DNA repair mechanisms and their clinical impact in glioblastoma","volume":"769","author":"Erasimus","year":"2016","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"issue":"12","key":"10.1016\/j.virusres.2019.197829_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116178","article-title":"Human cytomegalovirus gene expression in long-term infected glioma stem cells","volume":"9","author":"Fiallos","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.virusres.2019.197829_bib0050","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/jnci\/58.4.1003","article-title":"Human cells transformed in vitro by human cytomegalovirus: tumorigenicity in athymic nude mice","volume":"58","author":"Geder","year":"1977","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.virusres.2019.197829_bib0055","first-page":"139","article-title":"Cytomegalovirus and cancer of the prostate: in vitro transformation of human cells","volume":"61","author":"Geder","year":"1977","journal-title":"Cancer Treat. Rep."},{"issue":"5","key":"10.1016\/j.virusres.2019.197829_bib0060","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1462-5822.2012.01774.x","article-title":"Human cytomegalovirus persistence","volume":"14","author":"Goodrum","year":"2012","journal-title":"Cell. Microbiol."},{"issue":"2","key":"10.1016\/j.virusres.2019.197829_bib0065","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.4437","article-title":"The pathogenesis of human cytomegalovirus","volume":"235","author":"Griffiths","year":"2015","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.virusres.2019.197829_bib0070","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11060-011-0749-4","article-title":"Glioblastoma survival in the United States before and during the temozolomide era","volume":"107","author":"Johnson","year":"2012","journal-title":"J. Neurooncol."},{"issue":"3","key":"10.1016\/j.virusres.2019.197829_bib0075","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00137-17","article-title":"Human cytomegalovirus-infected glioblastoma cells display stem cell-like phenotypes","volume":"2","author":"Liu","year":"2017","journal-title":"mSphere"},{"issue":"19","key":"10.1016\/j.virusres.2019.197829_bib0080","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00866-07","article-title":"Long-term infection and shedding of human cytomegalovirus in T98G glioblastoma cells","volume":"81","author":"Luo","year":"2007","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2019.197829_bib0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.virusres.2019.197829_bib0090","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.chom.2014.02.011","article-title":"Human viral oncogenesis: a cancer hallmarks analysis","volume":"15","author":"Mesri","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.virusres.2019.197829_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00430-010-0177-7","article-title":"Oncomodulation by human cytomegalovirus: novel clinical findings open new roads","volume":"200","author":"Michaelis","year":"2011","journal-title":"Med. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.virusres.2019.197829_bib0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1215\/15228517-2007-035","article-title":"Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma","volume":"10","author":"Mitchell","year":"2008","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.virusres.2019.197829_bib0105","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1128\/JVI.06097-11","article-title":"Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples","volume":"86","author":"Ranganathan","year":"2012","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virusres.2019.197829_bib0110","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nrclinonc.2016.204","article-title":"Advances in the molecular genetics of gliomas - implications for classification and therapy","volume":"14","author":"Reifenberger","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.virusres.2019.197829_bib0115","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1128\/JVI.72.5.3729-3741.1998","article-title":"Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription","volume":"72","author":"Salvant","year":"1998","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.virusres.2019.197829_bib0120","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1158\/0008-5472.CAN-14-3307","article-title":"Cytomegalovirus immediate-early proteins promote stemness properties in glioblastoma","volume":"75","author":"Soroceanu","year":"2015","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.virusres.2019.197829_bib0125","doi-asserted-by":"crossref","DOI":"10.1186\/scrt96","article-title":"Interleukin-1\u03b2 and transforming growth factor-\u03b2 cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells","volume":"3","author":"Wang","year":"2012","journal-title":"Stem Cell Res. Ther."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170219305337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170219305337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:09:19Z","timestamp":1759154959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170219305337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":25,"alternative-id":["S0168170219305337"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2019.197829","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent HCMV infection of a glioblastoma cell line contributes to the development of resistance to temozolomide","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2019.197829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"197829"}}